Quaker Chemical Corp (NYSE:KWR) CEO Michael F. Barry Sells 3,834 Shares
Quaker Chemical Corp (NYSE:KWR) CEO Michael F. Barry sold 3,834 shares of the business’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $159.02, for a total transaction of $609,682.68. Following the sale, the chief executive officer now directly owns 156,301 shares in the company, valued at $24,854,985.02. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Shares of KWR traded up $2.87 during trading hours on Monday, reaching $162.63. The company’s stock had a trading volume of 3,709 shares, compared to its average volume of 94,653. The company has a 50 day moving average of $167.79 and a two-hundred day moving average of $193.29. The company has a quick ratio of 2.07, a current ratio of 2.69 and a debt-to-equity ratio of 0.07. The firm has a market cap of $2.12 billion, a price-to-earnings ratio of 26.92, a P/E/G ratio of 2.36 and a beta of 1.55. Quaker Chemical Corp has a 1-year low of $149.09 and a 1-year high of $224.30.
Quaker Chemical (NYSE:KWR) last posted its quarterly earnings results on Thursday, August 1st. The specialty chemicals company reported $1.56 EPS for the quarter, hitting the consensus estimate of $1.56. Quaker Chemical had a net margin of 6.69% and a return on equity of 18.35%. The business had revenue of $205.87 million during the quarter, compared to analysts’ expectations of $223.15 million. During the same period last year, the company posted $1.56 earnings per share. The firm’s quarterly revenue was down 7.2% compared to the same quarter last year. As a group, analysts forecast that Quaker Chemical Corp will post 6.11 EPS for the current fiscal year.
A number of hedge funds have recently added to or reduced their stakes in KWR. Price T Rowe Associates Inc. MD grew its holdings in shares of Quaker Chemical by 36.4% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 1,426,977 shares of the specialty chemicals company’s stock valued at $289,505,000 after acquiring an additional 380,431 shares in the last quarter. Nuveen Asset Management LLC acquired a new position in shares of Quaker Chemical in the second quarter worth $10,807,000. Atria Investments LLC acquired a new position in shares of Quaker Chemical in the second quarter worth $3,475,000. Copeland Capital Management LLC raised its holdings in shares of Quaker Chemical by 21.3% during the second quarter. Copeland Capital Management LLC now owns 165,914 shares of the specialty chemicals company’s stock worth $33,660,000 after acquiring an additional 29,122 shares in the last quarter. Finally, Morgan Stanley raised its holdings in shares of Quaker Chemical by 77.8% during the second quarter. Morgan Stanley now owns 61,166 shares of the specialty chemicals company’s stock worth $12,409,000 after acquiring an additional 26,770 shares in the last quarter. Institutional investors own 99.45% of the company’s stock.
Quaker Chemical Company Profile
Quaker Chemical Corporation develops, produces, and markets various formulated chemical specialty products for a range of heavy industrial and manufacturing applications in North America, Europe, the Middle East, Africa, the Asia/Pacific, and South America. The company's products include rolling lubricants used by manufacturers of steel in the hot and cold rolling of steel, and aluminum in the hot rolling of aluminum; machining and grinding compounds for use in cutting, shaping, and grinding metal parts; hydraulic fluids for steel, metalworking, and other customers to operate hydraulic equipment; corrosion preventives to protect metals during manufacture, storage, and shipment; and specialty greases used in automotive and aerospace production processes, steel manufacturing, and various other applications.
Read More: Depreciation
Receive News & Ratings for Quaker Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quaker Chemical and related companies with MarketBeat.com's FREE daily email newsletter.